Skip to main content

Perspective Therapeutics, Inc.

CATX
Exchange
NYSE
Industry
Pharmaceutical Preparations
SEC CIK
0000728387

In the last 90 days, Perspective Therapeutics, Inc. insiders filed 0 open-market purchases and 5 sales; 131 institutions reported holding it in 13F filings for Q2 2026, worth $297.6M in total; no superinvestor holds it.

Q2 2021 vs. Q1 2021

How the institutions holding Perspective Therapeutics, Inc. changed between Q1 2021 and Q2 2021.

All holders in Q2 2021All holders in Q1 2021

13F holders of CATX: Q1 2021 compared with Q2 2021
MeasureQ1 2021Q2 2021Change
Holders5748−9
Shares18.5M17.4M−1.16M (−6.3%)
Value$20.2M$13.9M−$6.35M (−31.4%)

New holders (8)

Institutions that held Perspective Therapeutics, Inc. at the end of Q2 2021 but not at the end of Q1 2021.

Institutions new to CATX in Q2 2021
InstitutionSharesValue% of portfolio
Strategic Wealth Advisors Group, LLC47,778$38.0K0.00%
Candriam Luxembourg S.C.A.34,883$28.0K0.00%
Signaturefd, LLC22,500$18.0K0.00%
Advisory Services Network, LLC1,000$1.00K0.00%
Bank of America Corp67$00.00%
FMR LLC56$00.00%
Horizon Financial Services, LLC350$00.00%
Wealth Quarterback LLC133––

Sold out (17)

Institutions that held Perspective Therapeutics, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.